{"id":"NCT02149199","sponsor":"AstraZeneca","briefTitle":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.","officialTitle":"A Clinical Study Comparing Symbicort® 'as Needed' With Terbutaline 'as Needed' and With Pulmicort® Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07-07","primaryCompletion":"2017-08-02","completion":"2017-08-02","firstPosted":"2014-05-29","resultsPosted":"2019-09-13","lastUpdate":"2019-11-15"},"enrollment":3850,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"budesonide/formoterol 'as needed' + budesonide placebo bid","otherNames":[]},{"type":"DRUG","name":"terbutaline 'as needed' + placebo budesonide bid","otherNames":[]},{"type":"DRUG","name":"budesonide bid + terbutaline 'as needed'","otherNames":[]}],"arms":[{"label":"Symbicort \"as needed\"+placebo Pulmicort bid","type":"EXPERIMENTAL"},{"label":"terbutaline \"as needed\"+placebo Pulmicort bid","type":"ACTIVE_COMPARATOR"},{"label":"Pulmicort bid + terbutaline \"as needed\"","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to test if Symbicort® (budesonide/formoterol) Turbuhaler® is effective in treating asthma when used 'as needed' in patients with milder asthma. The efficacy of Symbicort® 'as needed' will be compared with: 1) terbutaline Turbuhaler® 'as needed' and with 2) Pulmicort (budesonide) Turbuhaler® twice daily plus terbutaline Turbuhaler® 'as needed'.","primaryOutcome":{"measure":"'Well-controlled Asthma Week' - a Derived Binary Variable (Yes/No)","timeFrame":"Weekly, up to 52 weeks","effectByArm":[{"arm":"Placebo Bid + Symbicort 'as Needed'","deltaMin":34.4,"sd":36.02},{"arm":"Placebo Bid + Terbutaline 'as Needed'","deltaMin":31.1,"sd":34.9},{"arm":"Pulmicort Bid + Terbutaline 'as Needed'","deltaMin":44.4,"sd":39.1}],"pValues":[{"comp":"OG000 vs OG001","p":"0.046"},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":255,"countries":["Australia","Brazil","Bulgaria","Canada","Chile","China","Hungary","Mexico","Peru","Philippines","Poland","Romania","Russia","South Africa","South Korea","Ukraine","United Kingdom","Vietnam"]},"refs":{"pmids":["33548020","33010810","29768149","28069068","27912982"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=2648&filename=D589SC00001-statistical-analysis-plan-edition-4_29Sep2017_pdfa.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":1277},"commonTop":["Upper respiratory tract infection","Viral upper respiratory tract infection","Asthma","Pharyngitis","Bronchitis"]}}